Skip to content

MusclePharm Corporation: filings

Every MusclePharm Corporation annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filing record ends 2022-05-16

The latest filing in this captured record is a 10-Q filed 2022-05-16. No later filing is in the SEC companyfacts record captured on 2026-09-22. MusclePharm Corporation may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-05-16fiscal Q1 202242800001493152-22-013900
10-K/A2022-05-04fiscal FY 202150970001493152-22-012093
10-K2022-04-15fiscal FY 202150970001493152-22-010161
10-Q2021-11-17fiscal Q3 2021411160001493152-21-029042
10-Q2021-08-16fiscal Q2 202137970001493152-21-020219
10-Q2021-05-24fiscal Q1 202140790001493152-21-012724
10-K2021-03-29fiscal FY 202048960001493152-21-007088
10-Q2020-11-24fiscal Q3 2020461280001493152-20-022349
10-Q2020-11-24fiscal Q2 2020421110001493152-20-022348
10-Q2020-11-24fiscal Q1 202042840001493152-20-022347
10-K2020-08-25fiscal FY 2019442410001654954-20-009485
10-Q2020-08-25fiscal Q3 2019411330001654954-20-009484
10-Q2020-08-25fiscal Q2 2019411290001654954-20-009483
10-Q2020-08-25fiscal Q1 201941990001654954-20-009482
10-Q2018-11-14fiscal Q3 2018381000001654954-18-012576
10-Q2018-08-14fiscal Q2 2018381000001654954-18-009142
10-Q2018-05-15fiscal Q1 201837740001654954-18-005376
10-K2018-04-02fiscal FY 201740810001654954-18-003486
10-Q2017-11-14fiscal Q3 201737960001654954-17-010650
10-Q2017-08-14fiscal Q2 201736940001654954-17-007553
10-Q2017-05-12fiscal Q1 201736720001415684-17-000025
10-K2017-03-15fiscal FY 201639830001415684-17-000012
10-Q2016-11-09fiscal Q3 201636940001415684-16-000018
10-Q2016-08-09fiscal Q2 201636940001193125-16-676812
10-Q2016-05-10fiscal Q1 201637740001193125-16-585724
10-K2016-03-17fiscal FY 2015411030001193125-16-507417
10-Q2015-11-09fiscal Q3 2015421140001193125-15-372029
10-Q2015-08-10fiscal Q2 2015411140001193125-15-284945
10-Q2015-05-11fiscal Q1 201541820001564590-15-003962
10-K2015-03-16fiscal FY 2014411000001564590-15-001728
10-Q2014-11-14fiscal Q3 2014421110001564590-14-005822
10-Q2014-10-31fiscal Q2 2014421130001144204-14-064325
10-Q2014-08-05fiscal Q2 2014421130001144204-14-046854
10-Q2014-05-05fiscal Q1 201440780001144204-14-027406
10-K2014-03-31fiscal FY 201330580001144204-14-018989
10-Q/A2014-01-13fiscal Q3 201329670001144204-14-001716
10-Q/A2014-01-13fiscal Q2 201328660001144204-14-001709
10-Q/A2013-11-15fiscal Q3 201329670001144204-13-062485
10-Q2013-11-14fiscal Q3 201329670001144204-13-061840
10-Q2013-08-14fiscal Q2 201328660001144204-13-045393
10-Q2013-05-15fiscal Q1 201328560001144204-13-029435
10-K2013-04-01fiscal FY 201229610001144204-13-019317
10-Q/A2012-11-16fiscal Q3 201228660001144204-12-063571
10-Q/A2012-09-13fiscal Q2 201228660001144204-12-051303
10-Q/A2012-07-13fiscal Q2 201126620001144204-12-039394
10-K/A2012-07-09fiscal FY 201124480001144204-12-038531
10-Q/A2012-07-09fiscal Q3 201126630001144204-12-038527
10-Q/A2012-05-29fiscal Q1 201224460001144204-12-032157
10-K2012-04-16fiscal FY 201124480001144204-12-021909
10-Q2011-11-14fiscal Q3 201125590001144204-11-064430
10-K/A2011-09-27fiscal FY 201027540001144204-11-054873
10-Q/A2011-08-23fiscal Q2 201126620001144204-11-049223

Inspect the source

Entity
MusclePharm Corporation / CIK 0001415684
Captured
SEC response SHA-256
468a04d5e93b916c24c9590128d034d873e433232d8fd2a3bf40cb8a957ad42c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001415684.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))